FDA Advisors Likely To Discuss Gen AI Mental Health Device Transparency

By Christian Robles / September 25, 2025 at 4:27 PM

An FDA advisory committee meeting on generative artificial intelligence-enabled mental health devices is likely to highlight product transparency and risk mitigation strategies, as well as how FDA regulations apply to generative AI-powered products, multiple policy experts tell Inside Health Policy.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.